Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02565992
Title Phase I Study of Intratumoral CAVATAK and Pembrolizumab in Subjects With Advanced Melanoma
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Viralytics



Coxsackievirus A21 + Pembrolizumab

Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
John Wayne Cancer Institute Santa Monica California 90404 United States Details
Rutgers Cancer Institute of New Jersey New Brunswick New Jersey 08901 United States Details
Gabrail Cancer Center Research Canton Ohio 44718 United States Details
*Shaded cells indicate that there was no data available from for the field